Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Return on Equity (2019 - 2025)

AVITA Medical's Return on Equity history spans 7 years, with the latest figure at 4.17% for Q4 2025.

  • For Q4 2025, Return on Equity rose 418.0% year-over-year to 4.17%; the TTM value through Dec 2025 reached 4.17%, up 418.0%, while the annual FY2025 figure was 8.0%, 800.0% up from the prior year.
  • Return on Equity reached 4.17% in Q4 2025 per RCEL's latest filing, up from 1.35% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 4.17% in Q4 2025 to a low of 131.44% in Q1 2025.
  • Average Return on Equity over 5 years is 6.69%, with a median of 0.23% recorded in 2022.
  • The largest YoY upside for Return on Equity was 418bps in 2025 against a maximum downside of -13144bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.15% in 2021, then plummeted by -101bps to 0.31% in 2022, then soared by 154bps to 0.17% in 2023, then tumbled by -105bps to 0.01% in 2024, then surged by 52122bps to 4.17% in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Return on Equity are 4.17% (Q4 2025), 1.35% (Q3 2025), and 1.17% (Q2 2025).